Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BMN673 Is a PARP Inhibitor with Unique Radiosensitizing Properties: Mechanisms and Potential in Radiation Therapy. | Cancers (Basel) | 2022 | 36428712 | PubTator, text mining | PubMed |
| Interaction of Arsenic Exposure and Transcriptomic Profile in Basal Cell Carcinoma. | Cancers (Basel) | 2022 | 36428691 | PubTator, text mining | PubMed |
| The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis. | Antioxidants (Basel) | 2022 | 36421478 | PubTator, text mining | PubMed |
| Evolving DNA repair synthetic lethality targets in cancer. | Biosci Rep | 2022 | 36420962 | PubTator, text mining | PubMed |
| Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer. | Front Oncol | 2022 | 36419886 | PubTator, text mining | PubMed |
| A rapid multiplex cell-free assay on biochip to evaluate functional aspects of double-strand break repair. | Sci Rep | 2022 | 36414637 | PubTator, text mining | PubMed |
| Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer. | JCO Precis Oncol | 2022 | 36409970 | PubTator, text mining | PubMed |
| Polymorphisms of nucleotide excision repair genes associated with colorectal cancer risk: Meta-analysis and trial sequential analysis. | Front Genet | 2022 | 36386844 | PubTator, text mining | PubMed |
| Early recruitment of PARP-dependent m8A RNA methylation at DNA lesions is subsequently accompanied by active DNA demethylation. | RNA Biol | 2022 | 36382943 | PubTator, text mining | PubMed |
| NCAPH Stabilizes GEN1 in Chromatin to Resolve Ultra-Fine DNA Bridges and Maintain Chromosome Stability. | Mol Cells | 2022 | 36380731 | PubTator, text mining | PubMed |
| Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability. | PLoS Genet | 2022 | 36374936 | PubTator, text mining | PubMed |
| Interplay between the DNA Damage Response and Immunotherapy Response in Cancer. | Int J Mol Sci | 2022 | 36362142 | PubTator, text mining | PubMed |
| Contribution of Microhomology to Genome Instability: Connection between DNA Repair and Replication Stress. | Int J Mol Sci | 2022 | 36361724 | PubTator, text mining | PubMed |
| DNA Damage-Induced RNAPII Degradation and Its Consequences in Gene Expression. | Genes (Basel) | 2022 | 36360188 | PubTator, text mining | PubMed |
| Post-Translational Modifications by Lipid Metabolites during the DNA Damage Response and Their Role in Cancer. | Biomolecules | 2022 | 36359005 | PubTator, text mining | PubMed |
| Treatment of Human HeLa Cells with Black Raspberry Extracts Enhances the Removal of DNA Lesions by the Nucleotide Excision Repair Mechanism. | Antioxidants (Basel) | 2022 | 36358482 | PubTator, text mining | PubMed |
| DNA repair-related genes and adipogenesis: Lessons from congenital lipodystrophies. | Genet Mol Biol | 2022 | 36354755 | PubTator, text mining | PubMed |
| Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36338767 | PubTator, text mining | PubMed |
| ERCC1 is a potential biomarker for predicting prognosis, immunotherapy, chemotherapy efficacy, and expression validation in HER2 over-expressing breast cancer. | Front Oncol | 2022 | 36338712 | PubTator, text mining | PubMed |
| Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma. | Sci Rep | 2022 | 36335135 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers?page=22